FDA updates labeling for REZDIFFRA FDA Approval Dec. 31, 2025, 13:45 UTC Labeling changes approved for MADRIGAL. Active ingredient: RESMETIROM. Decision date: 12/19/2025 Full text
There are no comments here yet...